These results are interesting, because pathogenic GM-CSF+Th17 cell subsets, by promoting recruitment and activation of peripheral dendritic cells and monocytes, are implicated in MS pathogenesis [54–56], and this phenotype can also contribute to the infiltration of these phagocytes into CCM areas. The gene discussed is CSF2; the disease is myeloid sarcoma.